The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 772K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for F Roviezzo


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
13
Optimization of benzoquinone and hydroquinone derivatives as potent inhibitors of human 5-lipoxygenase.EBI
Second University of Naples
49
Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.EBI
University of Naples
18
Design and synthesis of functionalized 4-aryl-Catechol derivatives as new antiinflammtory agents with in vivo efficacy.EBI
University of Sannio
26
Design, Synthesis, and Pharmacological Characterization of a Potent Soluble Epoxide Hydrolase Inhibitor for the Treatment of Acute Pancreatitis.EBI
University of Salerno
27
Discovery and Optimization of Indoline-Based Compounds as Dual 5-LOX/sEH Inhibitors: EBI
University Federico Ii of Naples
47
Exploration of Long-Chain Vitamin E Metabolites for the Discovery of a Highly Potent, Orally Effective, and Metabolically Stable 5-LOX Inhibitor that Limits Inflammation.EBI
University of Innsbruck
31
Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin EEBI
Goethe-University Frankfurt
4
Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.EBI
University of Campania "Luigi Vanvitelli